Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Caris Life Sciences, Inc.CAI · Entity 3706 | Director | August 14, 2026 | August 14, 2026 |
| GLAUKOS CorpGKOS · Entity 3510 | PRESIDENT & COO | August 11, 2026 | August 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Caris Life Sciences, Inc.
Report date August 14, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,321 |
Reported balance
After 2026-08-14 transaction · row 1
1 source rowRow 1 · 2026-08-14 · Grant · Acquired 13,192 · Balance 29,321 F1: Represents an award of restricted stock units which vest in accordance with the applicable grant agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.
GLAUKOS Corp
Report date August 11, 2026 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 72,588 |
Last balance in matching sequence
After 2026-08-11 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
6 source rowsRow 1 · 2026-08-11 · Exercise / conversion · Acquired 10,000 · Balance 82,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 2 · 2026-08-11 · Exercise / conversion · Acquired 20,000 · Balance 102,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 3 · 2026-08-11 · Exercise / conversion · Acquired 20,000 · Balance 122,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 4 · 2026-08-11 · Exercise / conversion · Acquired 10,000 · Balance 132,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 5 · 2026-08-11 · Sale · Disposed 27,963 · Balance 104,625 F2: This transaction was executed in multiple trades at prices ranging from $178.60 to $179.58). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 6 · 2026-08-11 · Sale · Disposed 32,037 · Balance 72,588 F3: This transaction was executed in multiple trades at prices ranging from $179.68 to $180.60). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.18 · Expires 2032-03-24 | Direct | 51,475 |
Reported balance
After 2026-08-11 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-11 · Exercise / conversion · Disposed 20,000 · Balance 51,475 F4: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.18 · Expires 2032-03-24 | Direct | 33,118 |
Reported balance
After 2026-08-11 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-11 · Exercise / conversion · Disposed 20,000 · Balance 33,118 F5: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. F6: Total amount reported has been adjusted to correct a typographical error made in a Form 4 report filed by the Reporting Person on March 17, 2025, in which 13,721 stock options earned were erroneously reported as 13,271 stock options. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.46 · Expires 2033-03-22 | Direct | 26,751 |
Reported balance
After 2026-08-11 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-08-11 · Exercise / conversion · Disposed 10,000 · Balance 26,751 F7: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.46 · Expires 2033-03-22 | Direct | 26,751 |
Reported balance
After 2026-08-11 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-08-11 · Exercise / conversion · Disposed 10,000 · Balance 26,751 F8: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
F2: This transaction was executed in multiple trades at prices ranging from $178.60 to $179.58). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $179.68 to $180.60). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
F5: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals.
F6: Total amount reported has been adjusted to correct a typographical error made in a Form 4 report filed by the Reporting Person on March 17, 2025, in which 13,721 stock options earned were erroneously reported as 13,271 stock options.
F7: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
F8: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 14, 2026 21:41 UTC | Caris Life Sciences, Inc. CAI · Entity 3706 | GrantCommon Stock | 13,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001705850-26-000025 · wk-form4_1786743716.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,321 F1 · shares: Represents an award of restricted stock units which vest in accordance with the applicable grant agreement. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $48.46 | $0.00 |
DisclosureSEC source: 0001705850-26-000022 · form4-08132026_110855.xml · derivative · entry 10 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,751 Underlying: Common Stock · 10,000 shares Expires 2033-03-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $48.46 | $0.00 |
DisclosureSEC source: 0001705850-26-000022 · form4-08132026_110855.xml · derivative · entry 9 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,751 Underlying: Common Stock · 10,000 shares Expires 2033-03-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001705850-26-000022 · form4-08132026_110855.xml · derivative · entry 8 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,118 Underlying: Common Stock · 20,000 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. F6 · balance_after: Total amount reported has been adjusted to correct a typographical error made in a Form 4 report filed by the Reporting Person on March 17, 2025, in which 13,721 stock options earned were erroneously reported as 13,271 stock options. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001705850-26-000022 · form4-08132026_110855.xml · derivative · entry 7 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,475 Underlying: Common Stock · 20,000 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 32,037 | $180.49 | $5,782,358.13 |
DisclosureSEC source: 0001705850-26-000022 · form4-08132026_110855.xml · nonDerivative · entry 6 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,588 F3 · price: This transaction was executed in multiple trades at prices ranging from $179.68 to $180.60). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 27,963 | $178.89 | $5,002,301.07 |
DisclosureSEC source: 0001705850-26-000022 · form4-08132026_110855.xml · nonDerivative · entry 5 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,625 F2 · price: This transaction was executed in multiple trades at prices ranging from $178.60 to $179.58). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 10,000 | $48.46 | $484,600.00 |
DisclosureSEC source: 0001705850-26-000022 · form4-08132026_110855.xml · nonDerivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 20,000 | $55.18 | $1,103,600.00 |
DisclosureSEC source: 0001705850-26-000022 · form4-08132026_110855.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 20,000 | $55.18 | $1,103,600.00 |
DisclosureSEC source: 0001705850-26-000022 · form4-08132026_110855.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 10,000 | $48.46 | $484,600.00 |
DisclosureSEC source: 0001705850-26-000022 · form4-08132026_110855.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:06 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 1,056 | $142.57 | $150,553.92 |
DisclosureSEC source: 0001705850-26-000020 · form4-06292026_100612.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,363 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 18, 2021. F2 · balance_after: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 01, 2026 Filed May 4, 2026 22:12 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 19,573 | $143.54 | $2,809,508.42 |
DisclosureSEC source: 0001705850-26-000018 · form4-05042026_100505.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,419 F1 · balance_after: Includes 43,925 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 02, 2026 Filed Apr 4, 2026 01:17 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 3,169 | $109.60 | $347,322.40 |
DisclosureSEC source: 0001705850-26-000016 · form4-04042026_010442.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,992 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 14, 2024. F2 · balance_after: Includes 43,925 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 25, 2026 Filed Mar 28, 2026 00:31 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 36,751 | $0.00 Strike: $48.46 | $0.00 |
DisclosureSEC source: 0001705850-26-000014 · form4-03282026_120304.xml · derivative · entry 5 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,751 Underlying: Common Stock · 36,751 shares Expires 2033-03-14 F8 · shares: Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors determined on March 25, 2026 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. Read SEC document |
| March 25, 2026 Filed Mar 28, 2026 00:31 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 21,955 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001705850-26-000014 · form4-03282026_120304.xml · derivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,668 Underlying: Common Stock · 21,955 shares Expires 2032-03-24 F7 · shares: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. The Compensation, Nominating & Governance Committee determined on March 25, 2026 the level of achievement for the fourth year of the multi-year performance period. The number of shares of common stock subject to the stock option reported herein consists of the portion of the shares subject to the stock option that vested with respect to 100% of the fourth-year performance goal. Read SEC document |
| March 25, 2026 Filed Mar 28, 2026 00:31 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 16,462 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001705850-26-000014 · form4-03282026_120304.xml · derivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,475 Underlying: Common Stock · 16,462 shares Expires 2032-03-24 F5 · shares: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation Committee determined on December 15, 2022 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. F6 · derivative.exercise_date: 50% of the portion of the option reported herein will vest and become exercisable in March 2026. 50% of the portion of the option reported herein will vest and become exercisable in December 2026. Read SEC document |
| March 25, 2026 Filed Mar 28, 2026 00:31 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 17,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001705850-26-000014 · form4-03282026_120304.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,161 F3 · shares: Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date F4 · balance_after: Includes 49,754 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 25, 2026 Filed Mar 28, 2026 00:31 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 5,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001705850-26-000014 · form4-03282026_120304.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,369 F1 · shares: Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 14, 2024, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors determined on March 25, 2026 that certain of the operational targets had been achieved. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement of the operational target. 100% of the number of shares of common stock reported herein will vest and be delivered in March 2026. F2 · balance_after: Includes 31,962 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 24, 2026 Filed Mar 26, 2026 00:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 7,388 | $105.23 | $777,439.24 |
DisclosureSEC source: 0001705850-26-000012 · form4-03262026_120309.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,540 F3 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 24, 2022. F5 · balance_after: Includes 26,133 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 24, 2026 Filed Mar 26, 2026 00:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 4,926 | $105.23 | $518,362.98 |
DisclosureSEC source: 0001705850-26-000012 · form4-03262026_120309.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,928 F3 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 24, 2022. F4 · balance_after: Includes 39,725 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 23, 2026 Filed Mar 26, 2026 00:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 2,804 | $106.84 | $299,579.36 |
DisclosureSEC source: 0001705850-26-000012 · form4-03262026_120309.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,854 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 22, 2023. F2 · balance_after: Includes 48,787 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 16, 2026 Filed Mar 19, 2026 20:10 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 1,189 | $98.94 | $117,639.66 |
DisclosureSEC source: 0001705850-26-000010 · form4-03192026_040304.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,658 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 14, 2024. F2 · balance_after: Includes 53,986 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 13, 2026 Filed Mar 18, 2026 00:36 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 2,462 | $97.02 | $238,863.24 |
DisclosureSEC source: 0001705850-26-000008 · form4-03182026_120303.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,847 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 13, 2025. F2 · balance_after: Includes 56,132 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 22:49 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 1,057 | $119.17 | $125,962.69 |
DisclosureSEC source: 0001705850-26-000006 · form4-02262026_100216.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,309 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 18, 2021. F2 · balance_after: Includes 60,661 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,100 | $55.18 Strike: $55.18 | $171,058.00 |
DisclosureSEC source: 0001705850-26-000004 · form4-01272026_020151.xml · derivative · entry 7 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,713 Underlying: Common Stock · 3,100 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. F9 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,398 | $55.18 Strike: $55.18 | $408,221.64 |
DisclosureSEC source: 0001705850-26-000004 · form4-01272026_020151.xml · derivative · entry 6 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,013 Underlying: Common Stock · 7,398 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. F8 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 3,194 | $129.28 | $412,920.32 |
DisclosureSEC source: 0001705850-26-000004 · form4-01272026_020151.xml · nonDerivative · entry 5 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,366 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. F6 · price: This transaction was executed in multiple trades at prices ranging from $128.98 to $129.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 62,605 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 1,798 | $128.07 | $230,269.86 |
DisclosureSEC source: 0001705850-26-000004 · form4-01272026_020151.xml · nonDerivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,560 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $127.83 to $128.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 62,605 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 3,100 | $127.03 | $393,793.00 |
DisclosureSEC source: 0001705850-26-000004 · form4-01272026_020151.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,358 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $126.62 to $127.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 62,605 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,406 | $126.10 | $303,396.60 |
DisclosureSEC source: 0001705850-26-000004 · form4-01272026_020151.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,458 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $125.56 to $126.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 62,605 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 10,498 | $55.18 | $579,279.64 |
DisclosureSEC source: 0001705850-26-000004 · form4-01272026_020151.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 62,605 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 21, 2026 Filed Jan 24, 2026 01:42 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,900 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001705850-26-000002 · form4-01242026_010144.xml · derivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,813 Underlying: Common Stock · 1,900 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. F6 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. Read SEC document |
| January 21, 2026 Filed Jan 24, 2026 01:42 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,602 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001705850-26-000002 · form4-01242026_010144.xml · derivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,411 Underlying: Common Stock · 2,602 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. F5 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. Read SEC document |
| January 21, 2026 Filed Jan 24, 2026 01:42 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 4,502 | $124.65 | $561,174.30 |
DisclosureSEC source: 0001705850-26-000002 · form4-01242026_010144.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,366 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $124.47 to $124.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 62,605 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 21, 2026 Filed Jan 24, 2026 01:42 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 4,502 | $55.18 | $248,420.36 |
DisclosureSEC source: 0001705850-26-000002 · form4-01242026_010144.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 62,605 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 22:52 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 7,316 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001705850-25-000011 · form4-12152025_101217.xml · derivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,013 Underlying: Common Stock · 7,316 shares Expires 2032-03-24 F1 · shares: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee of the Issuer's Board of Directors determined that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. F2 · derivative.exercise_date: 50% of the portion of the option reported herein will vest and become exercisable in March 2026. 50% of the portion of the option reported herein will vest and become exercisable in December 2026. Read SEC document |
| November 18, 2025 Filed Nov 21, 2025 00:56 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 19,340 | $90.00 | $1,740,600.00 |
DisclosureSEC source: 0001705850-25-000009 · form4-11212025_121157.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,366 F1 · balance_after: Includes 62,605 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| September 23, 2025 Filed Sep 24, 2025 22:54 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 1,056 | $84.69 | $89,432.64 |
DisclosureSEC source: 0001705850-25-000007 · form4-09242025_100957.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,706 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 18, 2021. F2 · balance_after: Includes 62,605 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| September 18, 2025 Filed Sep 22, 2025 23:07 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 3,884 | $0.00 | $0.00 |
DisclosureSEC source: 0001705850-25-000005 · form4-09222025_110931.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,762 F1 · shares: Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 18, 2021, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee of the Issuer's Board of Directors determined on September 18, 2025 that two of the operational targets had been achieved. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement of the operational targets. 50% of the number of shares of common stock reported herein will vest and be delivered on September 23, 2025 and the remaining 50% will vest and be delivered in June 2026. F2 · balance_after: Includes 64,547 restricted stock units that have not yet vested or been delivered to the Reporting Person and 167 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan Read SEC document |
| May 28, 2025 Filed May 30, 2025 21:03 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 1,057 | $96.97 | $102,497.29 |
DisclosureSEC source: 0001415889-25-015022 · form4-05302025_090557.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,711 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 18, 2021. F2 · balance_after: Includes 60,663 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 00:03 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 1,922 | $97.09 | $186,606.98 |
DisclosureSEC source: 0001415889-25-009798 · form4-04032025_120454.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,768 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 18, 2021. F2 · balance_after: Includes 62,607 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 25, 2025 Filed Mar 27, 2025 23:12 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 2,891 | $96.60 | $279,270.60 |
DisclosureSEC source: 0001415889-25-009125 · form4-03272025_110359.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,690 F3 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 14, 2024. F2 · balance_after: Includes 66,482 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 25, 2025 Filed Mar 27, 2025 23:12 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 13,429 | $107.61 | $1,445,094.69 |
DisclosureSEC source: 0001415889-25-009125 · form4-03272025_110359.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,581 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 24, 2022 and March 22, 2023. F2 · balance_after: Includes 66,482 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 17, 2025 Filed Mar 17, 2025 23:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 1,028 | $102.19 | $105,051.32 |
DisclosureSEC source: 0001415889-25-008254 · form4-03172025_110347.xml · nonDerivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,010 F7 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 14, 2024. F8 · balance_after: Includes 94,294 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 23:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 13,271 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-25-008254 · form4-03172025_110347.xml · derivative · entry 5 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,713 Underlying: Common Stock · 13,271 shares Expires 2032-03-24 F9 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation Committee determined on March 13, 2025 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 23:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 18,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008254 · form4-03172025_110347.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,038 F5 · shares: Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date F6 · balance_after: Includes 96,479 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 23:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 5,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008254 · form4-03172025_110347.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,922 F3 · shares: Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 14, 2024, the earning and vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation Committee determined on March 13, 2025 that one of the operational targets had been achieved. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement of the operational target. 100% of the number of shares of common stock reported herein were vested and delivered on March 13, 2025. F4 · balance_after: Includes 84,192 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 23:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 3,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008254 · form4-03172025_110347.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,093 F1 · shares: Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 18, 2021, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee of the Issuer's Board of Directors ("Compensation Committee") determined on March 13, 2025 that one of the operational targets had been achieved. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement of the operational target. 50% of the number of shares of common stock reported hereinwill vest and be delivered in May 2025 and the remaining 50% will vest and be delivered in February 2026. F2 · balance_after: Includes 78,363 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| December 30, 2024 Filed Jan 3, 2025 01:32 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 7,318 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-25-000248 · form4-01032025_010135.xml · derivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,697 Underlying: Common Stock · 7,318 shares Expires 2032-03-24 F3 · shares: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors determined that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. F4 · derivative.exercise_date: 50% of the portion of the option reported herein will vest and become exercisable in March 2025, and the remaining 50% will vest and become exercisable in December 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.